These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 10564951)

  • 1. Analysis of genetic changes in intrahepatic cholangiocarcinoma induced by thorotrast.
    Kamikawa T; Amenomori M; Itoh T; Momoi H; Hiai H; Machinami R; Ishikawa Y; Mori T; Shimahara Y; Yamaoka Y; Fukumoto M
    Radiat Res; 1999 Dec; 152(6 Suppl):S118-24. PubMed ID: 10564951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability in thorotrast-induced human intrahepatic cholangiocarcinoma.
    Liu D; Momoi H; Li L; Ishikawa Y; Fukumoto M
    Int J Cancer; 2002 Dec; 102(4):366-71. PubMed ID: 12402306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholangiocarcinoma in association with Thorotrast exposure.
    Zhu AX; Lauwers GY; Tanabe KK
    J Hepatobiliary Pancreat Surg; 2004; 11(6):430-3. PubMed ID: 15619021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelotypic characteristics of thorotrast-induced intrahepatic cholangiocarcinoma: comparison to liver cancers not associated with thorotrast.
    Liu D; Wada I; Tateno H; Ogino D; Suzuki M; Li L; Lu W; Kojiro M; Fukayama M; Okabe H; Fukumoto M
    Radiat Res; 2004 Feb; 161(2):235-43. PubMed ID: 14731065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-particle carcinogenesis in Thorotrast patients: epidemiology, dosimetry, pathology, and molecular analysis.
    Ishikawa Y; Wada I; Fukumoto M
    J Environ Pathol Toxicol Oncol; 2001; 20(4):311-5. PubMed ID: 11797840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer genes and cholangiocarcinoma.
    Petmitr S
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 1():80-4. PubMed ID: 9656355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.
    Kang YK; Kim WH; Lee HW; Lee HK; Kim YI
    Lab Invest; 1999 Apr; 79(4):477-83. PubMed ID: 10212000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rate of small TP53 mutations and infrequent loss of heterozygosity in malignant liver tumors associated with thorotrast: implications for alpha-particle carcinogenesis.
    Wada I; Horiuchi H; Mori M; Ishikawa Y; Fukumoto M; Mori T; Kato Y; Kitagawa T; Machinami R
    Radiat Res; 1999 Dec; 152(6 Suppl):S125-7. PubMed ID: 10564952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients.
    Petmitr S; Pinlaor S; Thousungnoen A; Karalak A; Migasena P
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):71-5. PubMed ID: 9740272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathomorphological study of thorotrast-related intrahepatic cholangiocarcinoma--a comparison with non-thorotrast cases].
    Kojiro M; Sugihara S; Ito Y; Nakashima T; Ikezaki H; Mori T; Kido C
    Gan No Rinsho; 1986 Apr; 32(4):349-55. PubMed ID: 3012140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI appearance of thorotrast-induced cholangiocarcinoma in a case of thorotrastosis.
    Hayasaka K; Amoh K; Kakisaka A; Mito M
    Radiat Med; 1993; 11(2):60-2. PubMed ID: 8391154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Mutations in human cholangiocarcinoma: a review.
    Khan SA; Thomas HC; Toledano MB; Cox IJ; Taylor-Robinson SD
    Liver Int; 2005 Aug; 25(4):704-16. PubMed ID: 15998419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of p53 mutations for a mutational signature in human intrahepatic cholangiocarcinoma.
    Khan SA; Taylor-Robinson SD; Carmichael PL; Habib N; Lemoine NR; Thomas HC
    Int J Oncol; 2006 May; 28(5):1269-77. PubMed ID: 16596244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.
    Isa T; Tomita S; Nakachi A; Miyazato H; Shimoji H; Kusano T; Muto Y; Furukawa M
    Hepatogastroenterology; 2002; 49(45):604-8. PubMed ID: 12063950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas.
    Ohashi K; Tsutsumi M; Nakajima Y; Noguchi O; Okita S; Kitada H; Tsujiuchi T; Kobayashi E; Nakano H; Konishi Y
    Jpn J Clin Oncol; 1994 Dec; 24(6):305-10. PubMed ID: 7830335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proliferative lesions in thorotrast-deposited livers pertaining to the development of primary cancers].
    Tateno H; Hosoda S; Yamada S; Kido C
    Gan No Rinsho; 1984 Jan; 30(1):23-34. PubMed ID: 6321822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological type of Thorotrast-induced liver tumors associated with the translocation of deposited radionuclides.
    Yamamoto Y; Chikawa J; Uegaki Y; Usuda N; Kuwahara Y; Fukumoto M
    Cancer Sci; 2010 Feb; 101(2):336-40. PubMed ID: 19917057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Macroscopic study of cholangiocarcinoma].
    Maruiwa M; Sugihara S; Ito Y; Kojiro M
    Gan No Rinsho; 1987 Feb; 33(2):159-66. PubMed ID: 3031332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CT appearance of thorotrast-related and non-thorotrast-related peripheral cholangiocarcinoma].
    Sasaki F; Kido C; Ariyoshi Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Feb; 53(2):163-70. PubMed ID: 8387672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.
    Nakanuma Y; Harada K; Ishikawa A; Zen Y; Sasaki M
    J Hepatobiliary Pancreat Surg; 2003; 10(4):265-81. PubMed ID: 14598145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.